Skip to content

Air versus dye pyelogram in percutaneous nephrolithotripsy

Comparison of efficacy and adverse effects of air pyelogram with dye contrast pyelogram in percutaneous nephrolithotripsy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201302061323N6
Enrollment
250
Registered
2013-03-16
Start date
2008-04-03
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calculus of kidney with calculus of ureter. Calculus of kidney with calculus of ureter

Interventions

Intervention 1: In intervention group:use of 15-30 milliliter of room air as contrast agent for pyelogram and access to system for PCNL. Intervention 2: In control group:use meglumin 50 percent 15 -
Treatment - Surgery
Treatment - Drugs
In intervention group:use of 15-30 milliliter of room air as contrast agent for pyelogram and access to system for PCNL
In control group:use meglumin 50 percent 15 -30 milliliter as contrast agent for pyelogram and access to system for performing PCNL

Sponsors

Deputy of Information and Research , Yasuj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: inclusion and exclusion criteria are includes (Inclusion criteria:Age>18 years old :patients with renal or upper ureteral stone larger than 20 millimeter candidate for percutaneous nephrolithotripsy :Exclusion criteria: patients with urinary stone younger than 18 years old :patients with azotemia.uncontrolled coagulopathy:active infection:any contraindication for general or spinal anesthesia:COPD:ASA score 3 and 4 ) and history of DVT

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Visualizing pyelocaliceal system of kidneys and access to system. Timepoint: From begining of operation till access to system forPCNL. Method of measurement: Observation of surgen during operation by fluroscopy and by nephroscope after access to system.

Secondary

MeasureTime frame
Development of any cardiovascularcomplications. Timepoint: during operation, hospital stay and one week later. Method of measurement: report of patients and observation with examination of heart . pulse oximetery during operation and checking limb pulses.;Development of pulmonary complications. Timepoint: during operation, hospital stay and one week later. Method of measurement: report of patients and observation with examination of heart . pulse oximetery during operation and checking limb pulses.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Sadrollah Mehrabi

Social Health Determinant of research center, Yasuj university of medical science

sadrollahm@yahoo.com and dr mehrabiyums.ac.ir+98 74 1222 1813

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026